Top ICT spenders in the Australian Pharmaceutical Industry

Top ICT spenders in the Australian Pharmaceutical Industry

Code: KAB-KG1279DB | Published: Sep-2015 | Pages: 55 | Kable
Price :
$1,950.00
USD

* Required Fields

$1,950.00

Details

Top ICT spenders in the Australian pharmaceutical Industry presents the output from Kable's ICT spend prediction statistical model, a log-linear regression model that provides ICT spending predictions based on a company's demographic profile. The statistical model has been developed using an extensive collection of survey and interview data that Kable has conducted with ICT decision makers on their IT spending, as well as the insight of our analyst team.

Key Findings
Top ICT spenders in the Australian pharmaceutical Industry illustrates how Kable expects the top ICT spenders in the Australian pharmaceutical industry to allocate their ICT budgets across the core areas of enterprise ICT spend, namely hardware, software, IT services, communications and consulting.

Synopsis
The predictions were formulated in March 2015 following a large survey of ICT decision makers. Estimated trends in ICT spending have been identified through to the end of 2015 following feedback from respondents on their forthcoming investment plans.

Reasons To Buy
- Understand how the Australian pharmaceutical industry enterprise ICT landscape is set to change in 2015 to prioritize your target market.

- Make effective business decisions by recognizing the opportunities within each of the core areas of ICT spend (hardware, software, IT services, telecommunications, and consulting) .

- Realign your sales initiatives by understanding the current strategic objectives of the Australian pharmaceutical industry enterprises.

- Enhance your market segmentation with the included, detailed breakdown of opportunities within selected technology categories (enterprise application, business intelligence, and security products).

Table of Contents

1 Top-level ICT budget breakdowns
1.1 Introduction
2 Top ICT Spenders
3 CSL Limited
3.1 Estimated ICT budget breakdown by function
3.2 Estimated external ICT budget allocation by core technology area
3.3 Detailed ICT budget allocations
3.3.1 Estimated hardware budget breakdown
3.3.2 Estimated software budget breakdown by technology
3.3.3 Estimated software budget breakdown by type
3.3.4 Estimated IT services budget breakdown
3.3.5 Estimated IT consulting services budget breakdown
3.3.6 Estimated telecommunications budget breakdown
4 Sigma Pharmaceuticals Limited
4.1 Estimated ICT budget breakdown by function
4.2 Estimated external ICT budget allocation by core technology area
4.3 Detailed ICT budget allocations
4.3.1 Estimated hardware budget breakdown
4.3.2 Estimated software budget breakdown by technology
4.3.3 Estimated software budget breakdown by type
4.3.4 Estimated IT services budget breakdown
4.3.5 Estimated IT consulting services budget breakdown
4.3.6 Estimated telecommunications budget breakdown
5 Tasmanian Alkaloids Pty Ltd.
5.1 Estimated ICT budget breakdown by function
5.2 Estimated external ICT budget allocation by core technology area
5.3 Detailed ICT budget allocations
5.3.1 Estimated hardware budget breakdown
5.3.2 Estimated software budget breakdown by technology
5.3.3 Estimated software budget breakdown by type
5.3.4 Estimated IT services budget breakdown
5.3.5 Estimated IT consulting services budget breakdown
5.3.6 Estimated telecommunications budget breakdown
6 Johnson and Johnson Pty. Limited
6.1 Estimated ICT budget breakdown by function
6.2 Estimated external ICT budget allocation by core technology area
6.3 Detailed ICT budget allocations
6.3.1 Estimated hardware budget breakdown
6.3.2 Estimated software budget breakdown by technology
6.3.3 Estimated software budget breakdown by type
6.3.4 Estimated IT services budget breakdown
6.3.5 Estimated IT consulting services budget breakdown
6.3.6 Estimated telecommunications budget breakdown
7 Pfizer Australia Pty Limited
7.1 Estimated ICT budget breakdown by function
7.2 Estimated external ICT budget allocation by core technology area
7.3 Detailed ICT budget allocations
7.3.1 Estimated hardware budget breakdown
7.3.2 Estimated software budget breakdown by technology
7.3.3 Estimated software budget breakdown by type
7.3.4 Estimated IT services budget breakdown
7.3.5 Estimated IT consulting services budget breakdown
7.3.6 Estimated telecommunications budget breakdown
8 Merck Sharp and Dohme (Australia) Pty Limited
8.1 Estimated ICT budget breakdown by function
8.2 Estimated external ICT budget allocation by core technology area
8.3 Detailed ICT budget allocations
8.3.1 Estimated hardware budget breakdown
8.3.2 Estimated software budget breakdown by technology
8.3.3 Estimated software budget breakdown by type
8.3.4 Estimated IT services budget breakdown
8.3.5 Estimated IT consulting services budget breakdown
8.3.6 Estimated telecommunications budget breakdown
9 AstraZeneca Pty Limited
9.1 Estimated ICT budget breakdown by function
9.2 Estimated external ICT budget allocation by core technology area
9.3 Detailed ICT budget allocations
9.3.1 Estimated hardware budget breakdown
9.3.2 Estimated software budget breakdown by technology
9.3.3 Estimated software budget breakdown by type
9.3.4 Estimated IT services budget breakdown
9.3.5 Estimated IT consulting services budget breakdown
9.3.6 Estimated telecommunications budget breakdown
10 Sanofi-Aventis Australia Pty Ltd.
10.1 Estimated ICT budget breakdown by function
10.2 Estimated external ICT budget allocation by core technology area
10.3 Detailed ICT budget allocations
10.3.1 Estimated hardware budget breakdown
10.3.2 Estimated software budget breakdown by technology
10.3.3 Estimated software budget breakdown by type
10.3.4 Estimated IT services budget breakdown
10.3.5 Estimated IT consulting services budget breakdown
10.3.6 Estimated telecommunications budget breakdown
11 Aspen Pharmacare Australia Pty Limited
11.1 Estimated ICT budget breakdown by function
11.2 Estimated external ICT budget allocation by core technology area
11.3 Detailed ICT budget allocations
11.3.1 Estimated hardware budget breakdown
11.3.2 Estimated software budget breakdown by technology
11.3.3 Estimated software budget breakdown by type
11.3.4 Estimated IT services budget breakdown
11.3.5 Estimated IT consulting services budget breakdown
11.3.6 Estimated telecommunications budget breakdown
12 Alphapharm Pty Limited
12.1 Estimated ICT budget breakdown by function
12.2 Estimated external ICT budget allocation by core technology area
12.3 Detailed ICT budget allocations
12.3.1 Estimated hardware budget breakdown
12.3.2 Estimated software budget breakdown by technology
12.3.3 Estimated software budget breakdown by type
12.3.4 Estimated IT services budget breakdown
12.3.5 Estimated IT consulting services budget breakdown
12.3.6 Estimated telecommunications budget breakdown
13 Appendix
13.1 Definitions
13.2 Currency Conversion
13.3 Further reading
13.4 Contact the authors

List of Tables


Table 1: Top ICT spenders in Australian pharmaceutical industry
Table 2: CSL Limited will spend an estimated AUD 25m on its data centre
Table 3: CSL Limited will spend an estimated AUD 27m on hardware
Table 4: CSL Limited will spend an estimated AUD 4m on clients
Table 5: CSL Limited will spend an estimated AUD 4m on application lifecycle
Table 6: CSL Limited will spend an estimated AUD 6m on software licenses
Table 7: CSL Limited will spend an estimated AUD 4m on application development and integration
Table 8: CSL Limited will spend an estimated AUD 5m on systems planning and design consulting
Table 9: CSL Limited will spend an estimated AUD 4m on wireless data
Table 10: Sigma Pharmaceuticals Limited will spend an estimated AUD 18m on its data centre
Table 11: Sigma Pharmaceuticals Limited will spend an estimated AUD 19m on hardware
Table 12: Sigma Pharmaceuticals Limited will spend an estimated AUD 3m on clients
Table 13: Sigma Pharmaceuticals Limited will spend an estimated AUD 3m on application lifecycle
Table 14: Sigma Pharmaceuticals Limited will spend an estimated AUD 4m on software licenses
Table 15: Sigma Pharmaceuticals Limited will spend an estimated AUD 3m on application development and integration
Table 16: Sigma Pharmaceuticals Limited will spend an estimated AUD 3m on systems planning and design consulting
Table 17: Sigma Pharmaceuticals Limited will spend an estimated AUD 3m on wireless data
Table 18: Tasmanian Alkaloids Pty Ltd. will spend an estimated AUD 11m on its data centre
Table 19: Tasmanian Alkaloids Pty Ltd. will spend an estimated AUD 11m on hardware
Table 20: Tasmanian Alkaloids Pty Ltd. will spend an estimated AUD 2m on clients
Table 21: Tasmanian Alkaloids Pty Ltd. will spend an estimated AUD 2m on enterprise applications
Table 22: Tasmanian Alkaloids Pty Ltd. will spend an estimated AUD 2m on software licenses
Table 23: Tasmanian Alkaloids Pty Ltd. will spend an estimated AUD 2m on application development and integration
Table 24: Tasmanian Alkaloids Pty Ltd. will spend an estimated AUD 2m on systems planning and design consulting
Table 25: Tasmanian Alkaloids Pty Ltd. will spend an estimated AUD 2m on fixed voice
Table 26: Johnson and Johnson Pty. Limited will spend an estimated AUD 10m on its data centre
Table 27: Johnson and Johnson Pty. Limited will spend an estimated AUD 10m on hardware
Table 28: Johnson and Johnson Pty. Limited will spend an estimated AUD 2m on clients
Table 29: Johnson and Johnson Pty. Limited will spend an estimated AUD 1m on application lifecycle
Table 30: Johnson and Johnson Pty. Limited will spend an estimated AUD 2m on software licenses
Table 31: Johnson and Johnson Pty. Limited will spend an estimated AUD 2m on application development and integration
Table 32: Johnson and Johnson Pty. Limited will spend an estimated AUD 2m on systems planning and design consulting
Table 33: Johnson and Johnson Pty. Limited will spend an estimated AUD 1m on wireless data
Table 34: Pfizer Australia Pty Limited will spend an estimated AUD 8m on its data centre
Table 35: Pfizer Australia Pty Limited will spend an estimated AUD 8m on hardware
Table 36: Pfizer Australia Pty Limited will spend an estimated AUD 1m on clients
Table 37: Pfizer Australia Pty Limited will spend an estimated AUD 1m on application lifecycle
Table 38: Pfizer Australia Pty Limited will spend an estimated AUD 2m on software licenses
Table 39: Pfizer Australia Pty Limited will spend an estimated AUD 1m on application development and integration
Table 40: Pfizer Australia Pty Limited will spend an estimated AUD 1m on systems planning and design consulting
Table 41: Pfizer Australia Pty Limited will spend an estimated AUD 1m on wireless data
Table 42: Merck Sharp and Dohme (Australia) Pty Limited will spend an estimated AUD 6m on its data centre
Table 43: Merck Sharp and Dohme (Australia) Pty Limited will spend an estimated AUD 6m on hardware
Table 44: Merck Sharp and Dohme (Australia) Pty Limited will spend an estimated AUD 1m on clients
Table 45: Merck Sharp and Dohme (Australia) Pty Limited will spend an estimated AUD 1m on application lifecycle
Table 46: Merck Sharp and Dohme (Australia) Pty Limited will spend an estimated AUD 1m on software licenses
Table 47: Merck Sharp and Dohme (Australia) Pty Limited will spend an estimated AUD 1m on application development and integration
Table 48: Merck Sharp and Dohme (Australia) Pty Limited will spend an estimated AUD 1m on systems planning and design consulting
Table 49: Merck Sharp and Dohme (Australia) Pty Limited will spend an estimated AUD 1m on fixed voice
Table 50: AstraZeneca Pty Limited will spend an estimated AUD 5m on its data centre
Table 51: AstraZeneca Pty Limited will spend an estimated AUD 6m on hardware
Table 52: AstraZeneca Pty Limited will spend an estimated AUD 1m on clients
Table 53: AstraZeneca Pty Limited will spend an estimated AUD 1m on enterprise applications
Table 54: AstraZeneca Pty Limited will spend an estimated AUD 1m on software licenses
Table 55: AstraZeneca Pty Limited will spend an estimated AUD 1m on application development and integration
Table 56: AstraZeneca Pty Limited will spend an estimated AUD 1m on systems planning and design consulting
Table 57: AstraZeneca Pty Limited will spend an estimated AUD 1m on wireless data
Table 58: Sanofi-Aventis Australia Pty Ltd. will spend an estimated AUD 6m on its data centre
Table 59: Sanofi-Aventis Australia Pty Ltd. will spend an estimated AUD 6m on hardware
Table 60: Sanofi-Aventis Australia Pty Ltd. will spend an estimated AUD 1m on clients
Table 61: Sanofi-Aventis Australia Pty Ltd. will spend an estimated AUD 1m on application lifecycle
Table 62: Sanofi-Aventis Australia Pty Ltd. will spend an estimated AUD 1m on software licenses
Table 63: Sanofi-Aventis Australia Pty Ltd. will spend an estimated AUD 1m on application development and integration
Table 64: Sanofi-Aventis Australia Pty Ltd. will spend an estimated AUD 1m on systems planning and design consulting
Table 65: Sanofi-Aventis Australia Pty Ltd. will spend an estimated AUD 1m on fixed voice
Table 66: Aspen Pharmacare Australia Pty Limited will spend an estimated AUD 5m on its data centre
Table 67: Aspen Pharmacare Australia Pty Limited will spend an estimated AUD 6m on hardware
Table 68: Aspen Pharmacare Australia Pty Limited will spend an estimated AUD 1m on clients
Table 69: Aspen Pharmacare Australia Pty Limited will spend an estimated AUD 1m on application lifecycle
Table 70: Aspen Pharmacare Australia Pty Limited will spend an estimated AUD 1m on software licenses
Table 71: Aspen Pharmacare Australia Pty Limited will spend an estimated AUD 1m on application development and integration
Table 72: Aspen Pharmacare Australia Pty Limited will spend an estimated AUD 1m on systems planning and design consulting
Table 73: Aspen Pharmacare Australia Pty Limited will spend an estimated AUD 1m on fixed voice
Table 74: Alphapharm Pty Limited will spend an estimated AUD 4m on its data centre
Table 75: Alphapharm Pty Limited will spend an estimated AUD 5m on hardware
Table 76: Alphapharm Pty Limited will spend an estimated AUD 1m on clients
Table 77: Alphapharm Pty Limited will spend an estimated AUD 1m on application lifecycle
Table 78: Alphapharm Pty Limited will spend an estimated AUD 1m on software licenses
Table 79: Alphapharm Pty Limited will spend an estimated AUD 1m on application development and integration
Table 80: Alphapharm Pty Limited will spend an estimated AUD 1m on systems planning and design consulting
Table 81: Alphapharm Pty Limited will spend an estimated AUD 1m on fixed voice

List of Figures


Figure 1: Top ICT spenders in Australian pharmaceutical industry
CSL Limited
Sigma Pharmaceuticals Limited
Tasmanian Alkaloids Pty Ltd.
Johnson and Johnson Pty. Limited
Pfizer Australia Pty Limited
Merck Sharp and Dohme (Australia) Pty Limited
AstraZeneca Pty Limited
Sanofi-Aventis Australia Pty Ltd.
Aspen Pharmacare Australia Pty Limited
Alphapharm Pty Limited



Report Format

Following are different modes of Licenses.

a. Single User License:
This license allows only one person to use the report. This person can use the report on any computer and may take print outs of the report but must take care of not sharing the report (or any information contained therein) with any other individual or people. Unless you purchase a Site License or a Global Site License, a Single User License must be purchased for every single person that wishes to use the report within the same enterprise.

b. Single Site License:
This license allows unlimited users to use the report within one company location, e.g. a regional office. These users can use the report on any computer and may take print outs of the report but must take care of not sharing the report (or any information contained therein) with any other individual or people.

c. Global Site License:
A Global Site License (or Enterprise wide Site License or Global License) is a license granted to original purchaser, who can share a report with other employees and authorized Users of the same organization.

Quick Help

1. How do you deliver the reports?
The delivery of reports is depends on format & mode of license of report(s). Following are different kinds of formats of report(s) and their delivery options :

a. Electronic Format – Through email from Publisher
Report will be sent to your username email address in PDF, Excel, PowerPoint or any other electronic / softcopy format by publisher.
Delivery Time: 12 to 48 hours [depending on time difference or occurrences of national holidays]

b. Hard Copy or Printed Format or CD-Rom – Through Mail or Courier from Publisher
Report will be sent through mail / courier delivery to your shipping address by publisher.
Delivery Time: Less than, few weeks [depending on time difference or occurrences of national holidays]


2. How can I make payment for publications I purchase?
You could be able to make the payment, in following ways:

a. Online Secure Payment through Credit Card Payment : We accept Visa, Master, AMEX Cards & CCAvenue
b. Transfer of fund to our bank account via Bank transfer or Wire transfer
c. Payment via DD or Cheque
d. Paypal


3. Is it safe to use my credit card on MarketinfoResearch?
Your personal information and online tranaction on Marketinfo Research is secure, private, and tamper-proof. All credit card payments are processed through secure and trusted payment gateways.

If you have a more question about our publications please see our FAQs section or contact us now at cs@marketinforesearch.com.

CUSTOMERS WHO VIEWED THIS REPORT ALSO VIEWED

There are no reports matching the selection.

Browse similar reports by category:
ICT & Media
Kable

Our Clients